30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Graftys Completes Capital Raise for Expansion -

Graftys completed a €4.1MM (~US $4.6MM) funding round. Graftys markets Graftys® QuickSet calcium phosphate cement and Graftys® HBS injectable calcium phosphate bone graft substitute through distribution partnerships in over 25 countries. Proceeds will support global expansion by building new commercial/business development, clinical/regulatory and production capabilities in Belgium; reinforcing cement bulk production and creating a design unit in France; developing current markets such as Europe and the U.S.; and entering markets where Graftys has no current presence, such as Asia. Further, the company intends to develop new versions of existing products and new products with enhanced regenerative properties. (Graftys, 3/22/19)